Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine-HF: Long-term thiamine supplementation in heart failure
jRCT1051230004Recruiting
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of fursultiamine in heart failure (HF) and thiamine deficiency (2 arms). Primary endpoint: Time to first event of cardiovascular death or hospitalization for heart failure within 52 weeks. Started May 2023; status: recruiting.
02
Drugs
fursultiamine
03
Conditions
heart failure (HF)thiamine deficiency
Beyond the preview
Go deeper on jRCT1051230004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051230004.